Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2021 · 10-Q
Revenue$11.80M$11.80M+25.5% vs Q2 2020 Net Income-$12.51M-$12.51MN/M vs Q2 2020 EPS Diluted-$0.24-$0.24N/M vs Q2 2020 Gross Profit$8,155,484+22.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,958,981N/M Free Cash Flowderived-$3,092,229N/M Margins · derivedGross margin69.1%−1.8 pt vs Q2 2020
Operating margin-35.3%+24.3 pt vs Q2 2020
Net margin-106.0%
ended Mar 31, 2021 · filed May 12, 2021 · 42 d after period end